October 24, 2017
Los Angeles-based research company Science 37 announced the completion of a clinical study for AOBiome Therapeutics conducted entirely through a smartphone app.
The Phase 2b study ran on the back of Science 37’s mobile Network Oriented Research Assistant (NORA) platform, which allows for real-time video chat, customized self-photography models, data collection, and electronic consent. Science 37...
April 25, 2017
Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures -- contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. It's a large round with impressive investors, but it is technically a down round from last fall'...
October 21, 2015
Los Angeles-based mobile clinical trials company Science 37 has raised $6.5 million from Lux Capital and dRx Capital, a joint venture of Qualcomm and Novartis that launched in January.
The funding will help the company develop and roll out its novel clinical trial operating model, which uses mobile technology to allow patients to participate in the trial from their homes. The company draws on ...